Kamada's (TLV:KMDA) Earnings Are Of Questionable Quality
Mar 14
Israeli (TA) Healthcare Sector Analysis
UpdatedApr 26, 2024
DataAggregated Company Financials
Companies43
- 7D1.0%
- 3M-1.7%
- 1Y3.8%
- YTD-2.5%
The Healthcare industry is up 1.8% in the last week, with InterCure up 7.5%. In the same time, Pulsenmore was down 9.3%. In the last 12 months, the industry was up 5.0%. As for the next few years, earnings are expected to grow by 47% per annum.
Sector Valuation and Performance
Has the Israeli Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 26 Apr 2024 | ₪8.4b | ₪5.7b | -₪524,770,700.50 | 21.3x | -16.1x | 1.5x |
| Sun, 24 Mar 2024 | ₪8.9b | ₪5.6b | -₪461,983,466.50 | 17.8x | -19.2x | 1.6x |
| Tue, 20 Feb 2024 | ₪8.9b | ₪5.6b | -₪487,258,824.70 | 18.6x | -18.3x | 1.6x |
| Thu, 18 Jan 2024 | ₪8.9b | ₪5.7b | -₪598,004,836.00 | 16.3x | -14.9x | 1.6x |
| Sat, 16 Dec 2023 | ₪8.2b | ₪5.7b | -₪574,696,448.00 | 15.8x | -14.4x | 1.4x |
| Mon, 13 Nov 2023 | ₪8.3b | ₪5.6b | -₪594,422,263.00 | 12.8x | -14x | 1.5x |
| Wed, 11 Oct 2023 | ₪8.3b | ₪5.6b | -₪620,738,466.00 | 13x | -13.3x | 1.5x |
| Fri, 08 Sep 2023 | ₪8.7b | ₪5.6b | -₪563,172,393.00 | 13.8x | -15.5x | 1.6x |
| Sun, 06 Aug 2023 | ₪8.3b | ₪5.4b | -₪553,886,211.00 | 12.8x | -14.9x | 1.5x |
| Tue, 04 Jul 2023 | ₪8.2b | ₪5.4b | -₪562,256,043.00 | 10.4x | -14.5x | 1.5x |
| Thu, 01 Jun 2023 | ₪8.0b | ₪5.4b | -₪516,576,500.00 | 10x | -15.4x | 1.5x |
| Sat, 29 Apr 2023 | ₪8.0b | ₪5.3b | -₪468,647,819.00 | 8.6x | -17x | 1.5x |
| Mon, 27 Mar 2023 | ₪8.1b | ₪5.3b | -₪297,392,887.00 | 9.1x | -27.2x | 1.5x |
| Wed, 22 Feb 2023 | ₪8.5b | ₪5.1b | -₪375,371,565.00 | 9.3x | -22.5x | 1.7x |
| Fri, 20 Jan 2023 | ₪9.5b | ₪5.0b | -₪334,001,530.00 | 12.3x | -28.5x | 1.9x |
| Sun, 18 Dec 2022 | ₪8.9b | ₪5.0b | -₪343,536,640.00 | 10x | -26x | 1.8x |
| Tue, 15 Nov 2022 | ₪10.4b | ₪4.9b | -₪279,466,160.00 | 9.3x | -37.2x | 2.1x |
| Thu, 13 Oct 2022 | ₪10.6b | ₪5.0b | -₪295,576,882.00 | 9.2x | -35.7x | 2.1x |
| Sat, 10 Sep 2022 | ₪11.5b | ₪5.1b | -₪178,657,234.00 | 13x | -64.1x | 2.3x |
| Mon, 08 Aug 2022 | ₪12.7b | ₪5.0b | -₪137,707,834.00 | 11.9x | -92.1x | 2.5x |
| Wed, 06 Jul 2022 | ₪12.2b | ₪5.0b | -₪159,641,348.00 | 12x | -76.5x | 2.4x |
| Fri, 03 Jun 2022 | ₪12.9b | ₪5.0b | -₪225,942,007.00 | 14.3x | -57.3x | 2.6x |
| Sun, 01 May 2022 | ₪14.4b | ₪4.8b | -₪253,562,589.00 | 16.7x | -56.8x | 3x |
| Tue, 29 Mar 2022 | ₪15.5b | ₪4.8b | ₪106.0m | 16.1x | 145.9x | 3.2x |
| Thu, 24 Feb 2022 | ₪17.2b | ₪4.9b | -₪252,602,054.00 | 31.9x | -68.1x | 3.5x |
| Sat, 22 Jan 2022 | ₪16.8b | ₪4.8b | -₪227,247,495.00 | 31.8x | -74.1x | 3.5x |
| Mon, 20 Dec 2021 | ₪17.1b | ₪4.8b | -₪297,998,785.00 | 37x | -57.5x | 3.6x |
| Wed, 17 Nov 2021 | ₪17.1b | ₪4.8b | -₪217,579,543.00 | 20.7x | -78.5x | 3.6x |
| Fri, 15 Oct 2021 | ₪17.3b | ₪4.8b | -₪221,815,267.00 | 19.6x | -77.8x | 3.6x |
| Sun, 12 Sep 2021 | ₪17.1b | ₪4.7b | -₪222,462,883.50 | 19.4x | -76.8x | 3.6x |
| Tue, 10 Aug 2021 | ₪16.4b | ₪4.7b | -₪380,788,284.40 | 21.2x | -43.2x | 3.5x |
| Mon, 03 May 2021 | ₪14.9b | ₪4.6b | -₪324,278,773.00 | 17.8x | -46x | 3.3x |
Price to Earnings Ratio
-46x
Current Industry PE
- Investors are pessimistic on the Israeli Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 2.4x is higher than the industry's current PS ratio of 1.5x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have deteriorated over the last three years.
- Meanwhile revenues for these companies have grown 8.0% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.
Industry Trends
Which industries have driven the changes within the Israeli Healthcare sector?
| IL Market | 0.84% | |
| Healthcare | 1.00% | |
| Pharma | 7.22% | |
| Biotech | 1.92% | |
| Healthcare Services | 0.33% | |
| Healthtech | 0% | |
| Medical Equipment | -1.28% | |
| Life Sciences | -3.84% | |
Industry PE
- Investors are most optimistic about the Healthcare Services industry even though it's trading below its 3-year average PE ratio of 13.3x.
- It looks like they are confident that earnings will grow faster in the future than they have historically.
Forecasted Growth
- Analysts are most optimistic on the Medical Equipment industry, expecting annual earnings growth of 136% over the next 5 years.
- This is better than its past earnings decline of 35% per year.
- In contrast, the Biotech industry is expected to see its earnings grow by 28% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| INCR InterCure | ₪10.00 | 7.5% +₪31.9m | 19.8% | PE21.8x | |
| GOHO Golden House | ₪21.83 | 5.7% +₪18.2m | 94.9% | PE21x | |
| KMDA Kamada | ₪19.38 | 1.5% +₪16.7m | 17.4% | PE35.4x | |
| BKFR Bait Bakfar | ₪11.52 | 1.5% +₪11.9m | 19.3% | PE6.4x | |
| PPBT Purple Biotech | ₪0.21 | 17.7% +₪8.5m | -69.7% | PB0.4x |